MedTrace Logo

Accelerated Rehabilitation in Individuals After Total Knee Arthroplasty

NCT07319546 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-01-06

No results posted yet for this study

Summary

The primary aim of this double-blind randomized controlled trial is to evaluate the effectiveness of an accelerated rehabilitation protocol on knee joint function and quality of life in individuals undergoing TKA compared to conventional rehabilitation in Dali, Yunan, China. The study will include patients aged 50-80 years who are scheduled for primary unilateral TKA. Participants will be randomly assigned to either an accelerated rehabilitation group or conventional rehabilitation group. The primary outcomes will include knee joint function, assessed using the KOOS and quality of life measures using the SF-36 surveys. The study will follow participants for 6 months post-surgery to assess longer-term outcomes. This study will not include individuals undergoing revision TKA or those with severe comorbid conditions. The results will provide critical insights into the role of accelerated rehabilitation in improving post-operative recovery, functional outcomes, and overall quality of life for TKA patients.

Conditions

  • Knee Osteoarthristis
  • Arthroplasties, Knee Replacement

Interventions

BEHAVIORAL

Accelerated exercise

Based on optimal and accelerated concepts

BEHAVIORAL

Routine exercise

Conventional program

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Komsak Sinsurin, Ph.D., DPT · Mahidol University

  • Liying Yang · West Yunnan University of Applied Sciences, Yunnan province

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-12-30
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07319546 on ClinicalTrials.gov